High Septal Pacing for Cardiac Resynchronization Therapy (HISTORY)
High Septal Pacing for Cardiac Resynchronization Therapy Acute Research Study
Sponsor: Boston Scientific Corporation
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Boston Scientific Corporation
- Atrial Fibrillation Paroxysmal · Phase NA · Nov 2025
- Benign Prostatic Hyperplasia · Phase NA · Jul 2025
- Varicose Veins · Phase PHASE4 · Apr 2024
- Benign Biliary Strictures With Current or Prior Biliary Obstruction · Phase PHASE4 · Feb 2024
- Heart Failure NYHA Class II · Oct 2023
More terminations from Boston Scientific Corporation
Listed as NCT01325480, this observational or N/A phase trial focuses on Heart Disease and Heart Failure and remains terminated or withdrawn. Sponsored by Boston Scientific Corporation, it has been updated 7 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: EARLY_PHASE1 → None
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2018 [monthly]
Terminated EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Terminated Phase 0
First recorded
Aug 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Scientific Corporation
For direct contact, visit the study record on ClinicalTrials.gov .